Article

Academy of Managed Care Compass: The Top 5 Strategic Priorities

Conference|AMCP: The Academy of Managed Care Pharmacy

Edith Rosato, RPh, IOM, the chief executive officer of the Academy of Managed Care Pharmacy, recently shared the organization's Top 5 strategic priorities for the coming year.

Edith Rosato, RPh, IOM, the chief executive officer of the Academy of Managed Care Pharmacy, recently shared the organization’s Top 5 strategic priorities for the coming year.

“Managed care pharmacy is widely understood and accepted as integral to the delivery of quality and affordable health care,” commented Edith Rosato, RPh, IOM, chief executive officer of the Academy of Managed Care Pharmacy (AMCP), prior to one of the general sessions at the AMCP Educational Conference 2012.

During the conference, Ms Rosato took to the stage before former US Senator Bill Bradley to share 5 strategic priorities she planned to address in the coming year in order to make AMCP the go-to organization for information:

  • Being the leading provider of education, research, and resources for managed care pharmacy
  • Expanding the value of membership
  • Improving patient outcomes and healthcare affordability
  • Being the authoritative voice for managed care pharmacy
  • Executing with organizational excellence
Related Videos
James Chalmers, MD
Vincent Picozzi, MD, medical oncologist and director of the pancreaticobiliary program, Virginia Mason
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Priscilla Tsondai, MD, MPH, International AIDS Society/CIPHER
ASCO Preview 2025
James Chalmers, MD
Nini Wu, MD, Navista
ATS 2025
Bridgette J. Picou, LVN, ACLPN, The Well Project
Marla Black Morgan, MD, Phoebe Neurology Associates
Related Content
Lung cancer illustration | Image credit: SciePro - stock.adobe.com
May 31st 2025

Assay Finds Patients Who Will Benefit From Adjuvant Chemotherapy in Early-Stage NSCLC

Mary Caffrey
Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing and artificial intelligence could offer new tools for assessing risk.
Image of Managed Care Cast logo
August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

Maggie L. Shaw
At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Inflation Reduction Act | Image Credit: wladimir1804-stock.adobe.com
May 31st 2025

Community Oncology Bracing for IRA Impact

Maggie L. Shaw
Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking financial stability and patient access to care.
Managed Care Cast.
June 28th 2022

Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

Matthew Gavidia
On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
With approved gene therapies available for patients 4 years and older, the question of how early detection will impact the use of gene therapy in these patients remains. | Image credit: ChiccoDodiFC - stock.adobe.com
May 30th 2025

Navigating Hope, Risk, and the Unknown in a Changing DMD Treatment Landscape

Rose McNulty
PAH X-ray with pen | Image credit: Dzmitry – stock.adobe.com
May 30th 2025

Sotatercept for PAH Maintains Safety, Reduced Mortality in Long-Term Follow-Up

Hayden E. Klein
The pulmonary arterial hypertension (PAH) drug preserved its safety profile at 2.5 years of treatment and continued to reduce mortality compared with placebo.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo